Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • World
  • Can mechanics be related to drug resistance?

IISER Bhopal Life Science | DST-SERB | Junior Research Fellow Job

MACS ARI JRF Recruitment | Biotech & Life Sciences Apply

Can mechanics be related to drug resistance?
  • World

Can mechanics be related to drug resistance?

bioxone September 21, 2020September 21, 2020

In the last decade it has been seen that cancer has become really widespread, yet it has got no complete treatment as such till date. However, the therapeutic approach “chemotherapy” has saved the lives of millions. With the advent of the concept of “chemotherapeutic resistance”, the progress in the field of treatment of cancer has somewhat received a pause.


Chemotherapeutic resistance simply means that the cancer cells become resistant to chemotherapy and thus continue their uncontrolled growth even in the presence of chemotherapy. To combat this, biologists have proposed various mechanisms of how the resistance can be caused- some have hypothesized that drug inactivation by the host cells might be the cause, some pointed out that changes in the drug targets might cause the resistance, while some have blamed DNA mutations for this.


The study by researcher Rizzuti and group propose an entirely different mechanism behind this chemotherapeutic resistance. They have hypothesized that it is not only the events inside the cell that influence the process; the mechanical interactions between the cancer cells, connective tissues (or stromal cells) and the extracellular matrix also play key roles behind chemotherapeutic resistance. They have called these interactions as “tumor-stroma interactions”.

On applying “compressive stress” (a force to reduce the volume occupancy of a body) on the cancer cells, it was seen that the cell proliferation reduced. This in turn considerably diminished the efficiency of the drug (chemotherapy). In this way, mechanics (mechanical stress) was found to be involved in drug resistance.

Further, the study proposed that such mechanical manipulations of the microenvironment could be an innovative and promising therapeutic approach in the field of cancer.


This article has been published in Physical Review.


Source: Rizzuti I.F., Mascheroni P., Arcucci S., Ben-Mériem Z., Prunet A.,Barentin C., Rivière C., Delanoë-Ayari H., Hatzikirou H., Guillermet-Guibert J., Delarue M. ; (2020); Mechanical Control of Cell Proliferation Increases Resistance to Chemotherapeutic Agents; Physical Review Letters; Vol:125; Issue:12 https://doi.org/10.1103/PhysRevLett.125.

To find more news, please visit https://bioxone.in//


Written by Anuska Sen, Team bioXone

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Biomechanics cancer cell mechanics cell proliferation chemotherapeutic resistance chemotherapy compressive stress drug resistance therapeutics tumor

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship

MACS ARI JRF Recruitment | Biotech & Life Sciences Apply

bioxone September 21, 2020

MACS ARI JRF Recruitment – Biotech & Life Sciences Apply. MSc Biotech/Life Science JRF vacancy for eligible candidates. Research position vacant at MACS ARI, Pune. MACS ARI, Pune is hiring bsc candidates for project vacancies, interested and eligible candidates can check out all of the details on the JRF post given below: Job Name: Junior […]

MACS ARI JRF

Related Post

  • BiotechToday
  • India
  • World

Covid Update: Moderna Vaccine on the Horizon!

bioxone October 20, 2020October 20, 2020

Chitra Roy, University of Calcutta An American biotechnology company ‘Moderna’, based in Cambridge, Massachusetts focuses on the discovery and development of drugs in addition to vaccine technologies. They exclusively use messenger RNA (mRNA) therapeutics and designs vaccines to create a completely new generation of transformative medicines. Against COVID-19, Moderna has developed its mRNA vaccine candidate […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Regulatory expression of Co-inhibitory receptors by Type 1 Interferon transcriptional network in human T cells

bioxone November 2, 2020November 2, 2020

Rohit Bhattacharjee, Amity University Kolkata Although inhibition of T cell co-inhibitory receptors has brought about cancer therapy, mechanisms governing their expression on human T cells have not been explained. Type 1 interferon (IFN-I) regulates T cell immunity in viral infection, autoimmunity, cancer, and may enhance induction of T cell exhaustion in chronic viral infection. To […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

AXL receptor: a new companion of the ACE2 receptor which helps SARS-CoV-2 to enter the human body

bioxone January 16, 2021January 16, 2021

Parnad Basu, Amity University Kolkata The pandemic caused by COVID-19 is continuing still. The causative viral pathogen of COVID-19 is SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). This SARS-CoV-2 actually belongs to the β coronavirus genus along with SARS-CoV (severe acute respiratory syndrome coronavirus) and MERS-CoV (middle east respiratory syndrome coronavirus). Although SARS-CoV-2 targets the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy